DLX DELUXE CORP
Blankbooks, Looseleaf Binders & Bookbindg & Relatd Work · NYSE · SEC CIK 27996 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY0.4%
TTM net income YoY-3.4%
TTM EPS YoY-5.5%
Revenue 3-yr CAGR-1.4%
Net income 3-yr CAGR38.4%
Margins
Gross margin52.0%
Operating margin10.7%
Net margin3.8%
FCF margin10.1%
EBITDA margin18.0%
Returns
ROE11.6%
ROA2.7%
ROIC (approx.)6.6%
Asset turnover0.72x
Leverage & solvency
Liabilities / assets78.2%
Debt / equity2.79x
Current ratio1.07x
Interest coverage1.90x
Cash quality & payout
Operating cash flow / net income3.98x
Accruals ratio-8.1%
Payout ratio70.8%
Capex / revenue4.9%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $2.13B | $2.12B |
| Cost of revenue | $1.00B | $995.30M |
| Gross profit | $1.13B | $1.13B |
| SG&A expense | $873.30M | $909.20M |
| Operating income | $232.40M | $192.20M |
| Interest expense | $122.00M | $123.30M |
| Pretax income | $119.10M | $76.50M |
| Income tax | $36.90M | $23.60M |
| Net income | $82.10M | $52.80M |
| EBITDA | $370.30M | $357.70M |
| EPS (basic) | 1.83 | 1.20 |
| EPS (diluted) | 1.80 | 1.18 |
| Dividends declared per share | 1.20 | 1.20 |
| Weighted avg. shares (diluted) | 45.50M | 44.70M |
| Balance sheet | ||
| Cash & equivalents | $36.90M | $309.20M |
| Receivables | $187.60M | $174.10M |
| Inventory | $33.50M | $36.40M |
| Current assets | $665.80M | $611.60M |
| PP&E, net | $101.00M | $111.60M |
| Goodwill | $1.42B | $1.42B |
| Intangibles | $348.40M | $331.10M |
| Total assets | $2.86B | $2.83B |
| Current liabilities | $643.20M | $625.50M |
| Short-term debt | $16.30M | $37.10M |
| Long-term debt | $1.41B | $1.47B |
| Total debt | $1.43B | $1.50B |
| Total liabilities | $2.18B | $2.21B |
| Shareholders' equity | $680.40M | $620.70M |
| Net debt | $1.39B | $1.19B |
| Shares outstanding | 45.00M | 44.30M |
| Cash flow statement | ||
| Operating cash flow | $270.60M | $194.30M |
| Capital expenditure | $95.30M | $94.30M |
| Free cash flow | $175.30M | $100.00M |
| Investing cash flow | -$131.70M | -$69.80M |
| Financing cash flow | -$136.80M | -$267.20M |
| Depreciation & amortization | $137.90M | $165.50M |
| Stock-based compensation | $24.90M | $19.90M |
| Dividends paid | $55.20M | $54.20M |
Free plan shows the latest 2 periods; Pro shows all 18 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.